# Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup

**Authors:** Jianghua Ding, Shengping Gong

PMC · DOI: 10.3389/fphar.2024.1398879 · Frontiers in Pharmacology · 2024-05-09

## Full-text entities

- **Diseases:** multiple myeloma (MESH:D009101)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11111930/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11111930/full.md

---
Source: https://tomesphere.com/paper/PMC11111930